Nucleoside Metabolic Inhibitor [EPC]

Nucleoside Metabolic Inhibitor [EPC] was reported 274072 times

Drugs of the Nucleoside Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 148 0.9673
1 DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY 190 0.8920
2 THYMUS HYPOPLASIA 151 0.8678
3 HUMAN BOCAVIRUS INFECTION 135 0.7143
4 ACUTE MYELOID LEUKAEMIA RECURRENT 1178 0.5482
5 TUMOUR PERFORATION 140 0.4403
6 PIK3CA-ACTIVATED MUTATION 127 0.3825
7 CAECITIS 159 0.3533
8 NON-CIRRHOTIC PORTAL HYPERTENSION 132 0.3511
9 MYELODYSPLASTIC SYNDROME TRANSFORMATION 179 0.3436
10 NEUTROPENIC COLITIS 708 0.3420
11 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7563 0.3241
12 COLORECTAL CANCER METASTATIC 733 0.3090
13 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 196 0.2988
14 MANTLE CELL LYMPHOMA RECURRENT 128 0.2943
15 ARTERIOSPASM CORONARY 1172 0.2918
16 ANASTOMOTIC LEAK 202 0.2911
17 ACUTE MYELOID LEUKAEMIA 4251 0.2725
18 BLAST CELL COUNT INCREASED 263 0.2510
19 FUSARIUM INFECTION 175 0.2500
20 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 235 0.2482
21 FEBRILE BONE MARROW APLASIA 1053 0.2475
22 ACUTE PROMYELOCYTIC LEUKAEMIA 251 0.2442
23 MYCOBACTERIUM CHELONAE INFECTION 180 0.2436
24 PSEUDOMONAL SEPSIS 420 0.2396
25 VENOOCCLUSIVE LIVER DISEASE 1168 0.2363
26 FEBRILE NEUTROPENIA 15661 0.2358
27 SKIN TOXICITY 1315 0.2325
28 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 505 0.2288
29 SECONDARY IMMUNODEFICIENCY 277 0.2280
30 GASTROINTESTINAL TOXICITY 1075 0.2235
31 MUCOSAL INFLAMMATION 5782 0.2206
32 APLASIA 424 0.2163
33 DIFFERENTIATION SYNDROME 157 0.2139
34 LEUKAEMIA RECURRENT 355 0.2098
35 METASTASES TO SKIN 214 0.2072
36 GRANULOCYTE COUNT DECREASED 381 0.2053
37 HAEMATOTOXICITY 1948 0.2048
38 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 187 0.2022
39 TOXIC LEUKOENCEPHALOPATHY 145 0.1997
40 NEUTROPENIC INFECTION 190 0.1985
41 CHRONIC MYELOMONOCYTIC LEUKAEMIA 131 0.1985
42 MYELOSUPPRESSION 7058 0.1958
43 MYELOPATHY 353 0.1857
44 NEUTROPENIC SEPSIS 1309 0.1831
45 CARCINOEMBRYONIC ANTIGEN INCREASED 354 0.1826
46 BLOOD CULTURE POSITIVE 547 0.1825
47 HYPOFIBRINOGENAEMIA 178 0.1794
48 LEUKOENCEPHALOPATHY 661 0.1773
49 PARAINFLUENZAE VIRUS INFECTION 269 0.1766
50 ESCHERICHIA BACTERAEMIA 412 0.1751
51 PNEUMONIA FUNGAL 688 0.1742
52 METASTASES TO PLEURA 178 0.1697
53 KLEBSIELLA SEPSIS 191 0.1695
54 COLON CANCER METASTATIC 271 0.1680
55 RADIATION SKIN INJURY 194 0.1672
56 ENTERITIS 1066 0.1664
57 HYPERAMMONAEMIC ENCEPHALOPATHY 285 0.1638
58 METASTASES TO PERITONEUM 411 0.1626
59 TUMOUR LYSIS SYNDROME 1402 0.1592
60 VENOOCCLUSIVE DISEASE 398 0.1588
61 PNEUMATOSIS INTESTINALIS 451 0.1580
62 STREPTOCOCCAL BACTERAEMIA 171 0.1572
63 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 405 0.1568
64 METASTASES TO LIVER 2690 0.1529
65 PARONYCHIA 672 0.1528
66 STREPTOCOCCAL SEPSIS 180 0.1518
67 PSEUDOMONAL BACTERAEMIA 129 0.1511
68 ENTEROBACTER INFECTION 252 0.1498
69 DEVICE RELATED THROMBOSIS 147 0.1491
70 ENTEROCOLITIS 852 0.1474
71 HUMAN HERPESVIRUS 6 INFECTION 277 0.1464
72 SYSTEMIC MYCOSIS 171 0.1464
73 BONE MARROW FAILURE 2972 0.1461
74 FUNGAEMIA 227 0.1441
75 PERIPHERAL MOTOR NEUROPATHY 202 0.1441
76 PERIPHERAL SENSORY NEUROPATHY 841 0.1437
77 CYTOPENIA 1758 0.1434
78 ENTEROCOCCAL BACTERAEMIA 152 0.1434
79 DIFFUSE ALVEOLAR DAMAGE 164 0.1426
80 DERMATITIS ACNEIFORM 865 0.1420
81 NEUROTOXICITY 2437 0.1389
82 BRONCHOPULMONARY ASPERGILLOSIS 1077 0.1388
83 STENOTROPHOMONAS INFECTION 188 0.1385
84 MYELODYSPLASTIC SYNDROME 2002 0.1383
85 CARDIOTOXICITY 1229 0.1376
86 HYPERBILIRUBINAEMIA 1423 0.1372
87 METASTASES TO LUNG 1531 0.1324
88 PLATELET TRANSFUSION 163 0.1266
89 ESCHERICHIA SEPSIS 367 0.1265
90 GASTROINTESTINAL PERFORATION 524 0.1259
91 BREAST CANCER METASTATIC 1353 0.1259
92 SUBCLAVIAN VEIN THROMBOSIS 143 0.1255
93 PORTAL HYPERTENSION 385 0.1247
94 LYMPHANGIOSIS CARCINOMATOSA 128 0.1228
95 ADENOCARCINOMA OF COLON 230 0.1227
96 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 337 0.1218
97 NEOPLASM RECURRENCE 410 0.1208
98 DISEASE PROGRESSION 14282 0.1206
99 MUCORMYCOSIS 310 0.1192
100 BACTERIAL SEPSIS 384 0.1178
101 FEBRILE INFECTION 137 0.1164
102 CYTOMEGALOVIRUS CHORIORETINITIS 226 0.1158
103 SYSTEMIC CANDIDA 290 0.1154
104 METASTASES TO LYMPH NODES 777 0.1150
105 BONE MARROW TOXICITY 133 0.1122
106 LARYNGOSPASM 300 0.1114
107 GRAFT VERSUS HOST DISEASE IN SKIN 245 0.1111
108 ENTEROCOCCAL INFECTION 518 0.1071
109 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 228 0.1070
110 SOFT TISSUE INFECTION 196 0.1070
111 HYPOALBUMINAEMIA 831 0.1068
112 NEUTROPENIA 14507 0.1066
113 PHARYNGEAL INFLAMMATION 129 0.1061
114 ASPERGILLUS INFECTION 695 0.1058
115 BACTERAEMIA 1247 0.1050
116 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 147 0.1040
117 CAPILLARY LEAK SYNDROME 213 0.1029
118 SUBILEUS 212 0.1017
119 CENTRAL NERVOUS SYSTEM LYMPHOMA 140 0.1015
120 VIRAEMIA 140 0.1010
121 THERAPY PARTIAL RESPONDER 1576 0.1009
122 ACUTE LYMPHOCYTIC LEUKAEMIA 286 0.1009
123 METASTASES TO MENINGES 225 0.0989
124 JUGULAR VEIN THROMBOSIS 176 0.0988
125 ASPERGILLOSIS 129 0.0987
126 MANTLE CELL LYMPHOMA 150 0.0985
127 GENE MUTATION 195 0.0984
128 METASTASES TO CENTRAL NERVOUS SYSTEM 1264 0.0979
129 ONYCHOLYSIS 153 0.0978
130 CYSTITIS HAEMORRHAGIC 393 0.0974
131 NEUTROPHIL COUNT DECREASED 3921 0.0961
132 METASTASES TO BONE 1565 0.0953
133 POLYNEUROPATHY 1126 0.0940
134 SECOND PRIMARY MALIGNANCY 781 0.0938
135 ACUTE GRAFT VERSUS HOST DISEASE 429 0.0936
136 HEPATIC LESION 399 0.0922
137 STAPHYLOCOCCAL BACTERAEMIA 401 0.0922
138 VENA CAVA THROMBOSIS 153 0.0920
139 THROMBOCYTOPENIA 10283 0.0919
140 HYPERTRIGLYCERIDAEMIA 534 0.0911
141 GASTROINTESTINAL NECROSIS 261 0.0894
142 SEPTIC SHOCK 3883 0.0891
143 LIVER ABSCESS 289 0.0890
144 PANCYTOPENIA 4977 0.0890
145 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 838 0.0877
146 HYPERAMMONAEMIA 439 0.0877
147 METASTASIS 624 0.0873
148 STEROID DIABETES 131 0.0873
149 STEM CELL TRANSPLANT 217 0.0868
150 TUMOUR MARKER INCREASED 416 0.0866
151 STAPHYLOCOCCAL SEPSIS 428 0.0866
152 VENOUS THROMBOSIS 339 0.0863
153 NEUTROPHIL COUNT ABNORMAL 243 0.0859
154 GRAFT VERSUS HOST DISEASE 618 0.0859
155 NEOPLASM PROGRESSION 2952 0.0848
156 CHRONIC GRAFT VERSUS HOST DISEASE 306 0.0847
157 METASTASES TO SPINE 282 0.0838
158 LEFT VENTRICULAR DYSFUNCTION 557 0.0831
159 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 192 0.0825
160 CYTOMEGALOVIRUS INFECTION REACTIVATION 363 0.0821
161 KLEBSIELLA INFECTION 415 0.0820
162 STOMA SITE HAEMORRHAGE 126 0.0818
163 PROCTITIS 229 0.0817
164 PNEUMONIA KLEBSIELLA 149 0.0810
165 DISSEMINATED INTRAVASCULAR COAGULATION 1137 0.0807
166 CLOSTRIDIUM DIFFICILE COLITIS 856 0.0806
167 SMALL INTESTINAL PERFORATION 147 0.0783
168 ACUTE LEUKAEMIA 126 0.0780
169 STOMATITIS 4639 0.0764
170 CYTOMEGALOVIRUS VIRAEMIA 340 0.0764
171 LEUKOPENIA 3813 0.0762
172 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 252 0.0760
173 ADENOCARCINOMA 169 0.0753
174 NEUROPATHY PERIPHERAL 7173 0.0753
175 BREAST CANCER RECURRENT 238 0.0753
176 DIFFUSE LARGE B-CELL LYMPHOMA 577 0.0748
177 COMPUTERISED TOMOGRAM ABNORMAL 169 0.0745
178 ILEUS 912 0.0733
179 MALIGNANT NEOPLASM PROGRESSION 7491 0.0731
180 GASTRIC PERFORATION 199 0.0730
181 ADENOVIRUS INFECTION 211 0.0727
182 LUNG CONSOLIDATION 203 0.0725
183 LARGE INTESTINE PERFORATION 497 0.0715
184 RHINOVIRUS INFECTION 273 0.0701
185 HYPOMAGNESAEMIA 969 0.0695
186 RECURRENT CANCER 281 0.0688
187 METASTATIC NEOPLASM 296 0.0686
188 NECROTISING FASCIITIS 239 0.0677
189 OESOPHAGEAL CANDIDIASIS 270 0.0677
190 BLOOD BILIRUBIN INCREASED 1828 0.0676
191 ILEUS PARALYTIC 302 0.0676
192 BONE MARROW DISORDER 204 0.0675
193 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 256 0.0669
194 HYPOVOLAEMIC SHOCK 321 0.0669
195 INTESTINAL ISCHAEMIA 367 0.0666
196 ASCITES 1953 0.0664
197 CHOLANGITIS 409 0.0659
198 ORAL INTAKE REDUCED 159 0.0657
199 EJECTION FRACTION DECREASED 1021 0.0656
200 SEPSIS 7285 0.0653
201 AZOTAEMIA 259 0.0648
202 VARICES OESOPHAGEAL 196 0.0648
203 LUNG INFILTRATION 563 0.0637
204 CACHEXIA 327 0.0635
205 HYPOKALAEMIA 2921 0.0632
206 ORGANISING PNEUMONIA 312 0.0629
207 BLOOD LACTATE DEHYDROGENASE INCREASED 984 0.0620
208 HISTIOCYTOSIS HAEMATOPHAGIC 184 0.0619
209 VENTRICULAR HYPOKINESIA 196 0.0610
210 EMBOLISM 505 0.0607
211 CLOSTRIDIUM TEST POSITIVE 134 0.0607
212 INTESTINAL PERFORATION 680 0.0605
213 PORTAL VEIN THROMBOSIS 195 0.0603
214 BACTERIAL INFECTION 1124 0.0602
215 RECTAL CANCER 183 0.0595
216 CLOSTRIDIAL INFECTION 201 0.0594
217 TUMOUR HAEMORRHAGE 169 0.0592
218 DYSAESTHESIA 181 0.0590
219 CEREBELLAR SYNDROME 129 0.0588
220 LARGE INTESTINAL OBSTRUCTION 131 0.0586
221 PULMONARY HAEMORRHAGE 456 0.0582
222 PROCTALGIA 370 0.0575
223 ELECTROLYTE IMBALANCE 666 0.0573
224 ESCHERICHIA INFECTION 470 0.0571
225 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1609 0.0567
226 ACUTE RESPIRATORY DISTRESS SYNDROME 1004 0.0567
227 COLITIS 2148 0.0566
228 PANCREATIC CARCINOMA METASTATIC 161 0.0566
229 BLOOD ALBUMIN DECREASED 446 0.0562
230 BONE LESION 202 0.0560
231 PERFORMANCE STATUS DECREASED 260 0.0557
232 STRESS CARDIOMYOPATHY 323 0.0555
233 PSEUDOMONAS INFECTION 476 0.0555
234 WOUND DEHISCENCE 187 0.0553
235 NEUROLOGICAL DECOMPENSATION 128 0.0553
236 MULTI-ORGAN FAILURE 946 0.0547
237 ABDOMINAL INFECTION 139 0.0544
238 BK VIRUS INFECTION 183 0.0542
239 ACUTE CORONARY SYNDROME 449 0.0542
240 PLATELET COUNT DECREASED 5761 0.0540
241 STRIDOR 159 0.0540
242 ATELECTASIS 521 0.0539
243 SMALL INTESTINAL OBSTRUCTION 660 0.0536
244 HICCUPS 439 0.0534
245 GUILLAIN-BARRE SYNDROME 258 0.0533
246 HEPATOTOXICITY 1183 0.0531
247 DEVICE RELATED INFECTION 813 0.0528
248 MULTIPLE-DRUG RESISTANCE 163 0.0525
249 VASCULAR DEVICE INFECTION 238 0.0524
250 HYDRONEPHROSIS 389 0.0519
251 OESOPHAGITIS 567 0.0518
252 INVASIVE DUCTAL BREAST CARCINOMA 141 0.0518
253 EMBOLISM VENOUS 157 0.0517
254 HYPERTRANSAMINASAEMIA 360 0.0517
255 HERPES SIMPLEX 336 0.0516
256 CARDIOMYOPATHY 755 0.0510
257 HOSPICE CARE 504 0.0510
258 LUNG OPACITY 134 0.0508
259 HAEMOGLOBIN ABNORMAL 327 0.0508
260 CANCER PAIN 129 0.0504
261 AGRANULOCYTOSIS 936 0.0503
262 OESOPHAGEAL STENOSIS 143 0.0502
263 HEPATITIS B REACTIVATION 159 0.0500
264 PARAPLEGIA 143 0.0495
265 HEPATOSPLENOMEGALY 127 0.0494
266 PROTEINURIA 940 0.0494
267 VENTRICULAR DYSFUNCTION 128 0.0493
268 HYPOGAMMAGLOBULINAEMIA 324 0.0493
269 WHITE BLOOD CELL COUNT DECREASED 5339 0.0492
270 HYPERPYREXIA 208 0.0491
271 BRAIN ABSCESS 124 0.0490
272 PNEUMOCYSTIS JIROVECII PNEUMONIA 492 0.0490
273 VENTRICULAR FIBRILLATION 544 0.0489
274 CONGESTIVE CARDIOMYOPATHY 202 0.0484
275 GRANULOCYTOPENIA 275 0.0482
276 JAUNDICE CHOLESTATIC 170 0.0481
277 PLEURAL EFFUSION 2927 0.0481
278 PNEUMONITIS 1305 0.0479
279 HYPOPHOSPHATAEMIA 354 0.0479
280 PULMONARY TOXICITY 336 0.0475
281 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 356 0.0474
282 LYMPHOPENIA 665 0.0470
283 SPLENOMEGALY 549 0.0468
284 MYELOFIBROSIS 141 0.0466
285 LUNG NEOPLASM 199 0.0465
286 PULMONARY ALVEOLAR HAEMORRHAGE 261 0.0465
287 ANAEMIA 8717 0.0457
288 NEPHROPATHY TOXIC 513 0.0457
289 TRANSFUSION 477 0.0455
290 THROMBOTIC MICROANGIOPATHY 438 0.0449
291 NAIL DISORDER 392 0.0448
292 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 224 0.0440
293 ODYNOPHAGIA 262 0.0438
294 CARDIAC FAILURE ACUTE 291 0.0436
295 RASH PUSTULAR 318 0.0436
296 HEPATIC FAILURE 1315 0.0436
297 BLOOD CREATININE DECREASED 136 0.0434
298 HYPOVOLAEMIA 254 0.0434
299 WHITE BLOOD CELL COUNT ABNORMAL 277 0.0434
300 INTERSTITIAL LUNG DISEASE 2096 0.0432
301 APLASTIC ANAEMIA 226 0.0432
302 CYTOKINE RELEASE SYNDROME 867 0.0432
303 LEFT VENTRICULAR FAILURE 148 0.0429
304 PERIPHERAL ISCHAEMIA 173 0.0423
305 CATHETER SITE INFECTION 160 0.0423
306 HEPATIC FUNCTION ABNORMAL 1552 0.0415
307 EPSTEIN-BARR VIRUS INFECTION 259 0.0414
308 PLATELET COUNT ABNORMAL 249 0.0412
309 ABDOMINAL ABSCESS 182 0.0411
310 CANDIDIASIS 165 0.0411
311 MALNUTRITION 459 0.0410
312 RESPIRATORY FAILURE 2981 0.0408
313 HYPERURICAEMIA 168 0.0408
314 HEPATIC NEOPLASM 133 0.0407
315 ENCEPHALOPATHY 1000 0.0407
316 CARDIAC DYSFUNCTION 151 0.0405
317 NECROSIS 225 0.0404
318 SKIN FISSURES 788 0.0403
319 FAILURE TO THRIVE 209 0.0402
320 ACUTE PULMONARY OEDEMA 225 0.0400
321 PERICARDIAL EFFUSION 922 0.0398
322 CARDIAC TAMPONADE 189 0.0397
323 DEHYDRATION 5300 0.0397
324 HEPATIC CYTOLYSIS 506 0.0396
325 THROMBOPHLEBITIS 139 0.0396
326 CANDIDA INFECTION 669 0.0396
327 TOXIC ENCEPHALOPATHY 200 0.0394
328 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 325 0.0394
329 HYPOCALCAEMIA 738 0.0390
330 ENCEPHALITIS 269 0.0388
331 PROTEIN TOTAL DECREASED 146 0.0387
332 EXTRAVASATION 159 0.0386
333 ONYCHOMADESIS 162 0.0386
334 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 228 0.0385
335 ACIDOSIS 294 0.0384
336 IMMUNE THROMBOCYTOPENIA 176 0.0384
337 INTESTINAL OBSTRUCTION 1445 0.0383
338 CEREBRAL ISCHAEMIA 196 0.0381
339 HYPERNATRAEMIA 189 0.0379
340 ISCHAEMIA 173 0.0376
341 DIARRHOEA 24111 0.0373
342 LEUKOCYTOSIS 675 0.0373
343 TRANSAMINASES INCREASED 828 0.0372
344 ANAL ABSCESS 200 0.0371
345 HEPATIC CYST 126 0.0371
346 CHOLESTASIS 710 0.0369
347 HYPOXIA 1302 0.0369
348 NEPHROTIC SYNDROME 253 0.0369
349 CYTOMEGALOVIRUS INFECTION 612 0.0368
350 PIGMENTATION DISORDER 227 0.0367
351 BLOOD LACTIC ACID INCREASED 193 0.0366
352 SUDDEN DEATH 387 0.0365
353 TEMPERATURE INTOLERANCE 375 0.0363
354 LEUKAEMIA 341 0.0361
355 COAGULOPATHY 600 0.0360
356 CHRONIC MYELOID LEUKAEMIA 164 0.0355
357 HEPATITIS B 214 0.0355
358 GASTROINTESTINAL INFLAMMATION 278 0.0355
359 CARDIOPULMONARY FAILURE 138 0.0354
360 NO THERAPEUTIC RESPONSE 431 0.0353
361 ASPARTATE AMINOTRANSFERASE INCREASED 1877 0.0353
362 MYOCARDIAL ISCHAEMIA 402 0.0353
363 MOUTH ULCERATION 738 0.0350
364 PYREXIA 12114 0.0350
365 PNEUMONIA BACTERIAL 321 0.0349
366 HEPATOMEGALY 343 0.0349
367 PULMONARY MASS 519 0.0348
368 HAEMOLYTIC ANAEMIA 312 0.0348
369 RED CELL DISTRIBUTION WIDTH INCREASED 144 0.0346
370 ALANINE AMINOTRANSFERASE INCREASED 2118 0.0345
371 PROTHROMBIN TIME PROLONGED 206 0.0344
372 CHOLECYSTITIS ACUTE 195 0.0344
373 DRUG TOXICITY 468 0.0343
374 NEOPLASM 393 0.0342
375 COLON CANCER 509 0.0341
376 CARDIOGENIC SHOCK 490 0.0341
377 THROMBOCYTOSIS 125 0.0341
378 HAEMODYNAMIC INSTABILITY 259 0.0340
379 BLOOD ALKALINE PHOSPHATASE INCREASED 841 0.0338
380 INFECTION 4895 0.0338
381 FUNGAL INFECTION 1123 0.0337
382 AMYLASE INCREASED 124 0.0336
383 RESPIRATORY DISTRESS 927 0.0336
384 ANOREXIA 431 0.0334
385 DRUG RESISTANCE 852 0.0331
386 LUNG INFECTION 515 0.0331
387 TACHYPNOEA 450 0.0331
388 CHEILITIS 179 0.0331
389 HYPOPHAGIA 844 0.0330
390 JAUNDICE 888 0.0330
391 OLIGURIA 204 0.0328
392 INTRACRANIAL PRESSURE INCREASED 183 0.0328
393 SINUS TACHYCARDIA 465 0.0327
394 GAMMA-GLUTAMYLTRANSFERASE INCREASED 725 0.0327
395 HYPERTHERMIA 248 0.0325
396 COLITIS ISCHAEMIC 218 0.0323
397 ENDOCARDITIS 165 0.0321
398 MYOCARDITIS 368 0.0321
399 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 162 0.0320
400 BRAIN OEDEMA 404 0.0320
401 PETECHIAE 332 0.0318
402 GENERAL PHYSICAL HEALTH DETERIORATION 3676 0.0317
403 PULMONARY EMBOLISM 2999 0.0315
404 HAEMOGLOBIN DECREASED 3237 0.0315
405 ESCHERICHIA URINARY TRACT INFECTION 134 0.0315
406 BLOOD MAGNESIUM DECREASED 272 0.0315
407 SHOCK HAEMORRHAGIC 256 0.0314
408 PHLEBITIS 161 0.0314
409 DUODENAL ULCER 221 0.0313
410 RED BLOOD CELL COUNT DECREASED 888 0.0310
411 LIPASE INCREASED 237 0.0309
412 HEPATOCELLULAR INJURY 438 0.0309
413 ABDOMINAL TENDERNESS 153 0.0308
414 ACUTE RESPIRATORY FAILURE 592 0.0307
415 TROPONIN INCREASED 234 0.0307
416 STAPHYLOCOCCAL INFECTION 1013 0.0307
417 LYMPHOEDEMA 211 0.0305
418 CHOLECYSTITIS 363 0.0304
419 SKIN REACTION 429 0.0304
420 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 310 0.0302
421 FULL BLOOD COUNT DECREASED 607 0.0301
422 PAPILLOEDEMA 136 0.0301
423 HEPATIC ENCEPHALOPATHY 281 0.0301
424 SUSPECTED OFF LABEL USE 136 0.0301
425 DECREASED APPETITE 6980 0.0300
426 TOXIC SKIN ERUPTION 302 0.0300
427 SKIN NECROSIS 154 0.0297
428 ATAXIA 352 0.0296
429 BLOOD DISORDER 237 0.0296
430 HYPERGLYCAEMIA 1077 0.0295
431 ORAL DISORDER 216 0.0294
432 LYMPHADENOPATHY 1043 0.0294
433 PULSE ABSENT 140 0.0294
434 DIARRHOEA HAEMORRHAGIC 274 0.0293
435 ORAL PAIN 654 0.0292
436 SUBDURAL HAEMATOMA 418 0.0292
437 SUPRAVENTRICULAR TACHYCARDIA 279 0.0291
438 BLOOD CREATINE INCREASED 129 0.0291
439 HAEMOLYSIS 224 0.0290
440 SERUM FERRITIN INCREASED 153 0.0290
441 MOUTH HAEMORRHAGE 211 0.0288
442 HYPERAESTHESIA 236 0.0287
443 SKIN HYPERPIGMENTATION 246 0.0286
444 RENAL FAILURE ACUTE 1213 0.0286
445 PNEUMOTHORAX 453 0.0285
446 HYPONATRAEMIA 1606 0.0285
447 C-REACTIVE PROTEIN INCREASED 1036 0.0284
448 IMMUNOSUPPRESSION 251 0.0284
449 METABOLIC DISORDER 165 0.0284
450 VOMITING 13272 0.0282
451 NEUROLOGICAL SYMPTOM 161 0.0281
452 OSTEONECROSIS OF JAW 694 0.0280
453 PATHOLOGICAL FRACTURE 142 0.0280
454 RASH MACULO-PAPULAR 622 0.0279
455 PERITONITIS 577 0.0278
456 BLOOD UREA INCREASED 466 0.0278
457 FLUID INTAKE REDUCED 139 0.0278
458 STREPTOCOCCAL INFECTION 154 0.0276
459 HAEMORRHAGE INTRACRANIAL 408 0.0273
460 DEEP VEIN THROMBOSIS 1760 0.0271
461 FAECALOMA 148 0.0270
462 GINGIVAL BLEEDING 366 0.0268
463 SUBARACHNOID HAEMORRHAGE 273 0.0268
464 RALES 155 0.0267
465 APPENDICITIS 249 0.0266
466 HEMIPARESIS 451 0.0266
467 ANAL FISTULA 142 0.0266
468 CIRCULATORY COLLAPSE 449 0.0263
469 SQUAMOUS CELL CARCINOMA OF SKIN 159 0.0263
470 LIVER INJURY 643 0.0262
471 ORAL CANDIDIASIS 344 0.0261
472 BLOOD CREATININE INCREASED 1704 0.0261
473 HAEMODIALYSIS 219 0.0261
474 DISEASE RECURRENCE 1237 0.0260
475 HEPATIC STEATOSIS 484 0.0260
476 DRUG-INDUCED LIVER INJURY 815 0.0259
477 PULMONARY OEDEMA 1162 0.0259
478 SHOCK 587 0.0255
479 MYOSITIS 229 0.0255
480 CEREBRAL HAEMORRHAGE 911 0.0254
481 FISTULA 286 0.0254
482 ONYCHOCLASIS 175 0.0254
483 DERMATITIS BULLOUS 184 0.0254
484 CELLULITIS 1280 0.0254
485 HAEMATOCRIT DECREASED 503 0.0253
486 HAEMATEMESIS 642 0.0253
487 ANURIA 217 0.0252
488 LYMPHOCYTE COUNT DECREASED 443 0.0250
489 BLOOD POTASSIUM DECREASED 752 0.0250
490 BODY TEMPERATURE INCREASED 510 0.0250
491 TRISMUS 129 0.0250
492 GENERALISED OEDEMA 309 0.0249
493 ABDOMINAL PAIN 5783 0.0248
494 EPISTAXIS 1859 0.0248
495 ANAL FISSURE 133 0.0248
496 PURPURA 217 0.0245
497 CEREBRAL INFARCTION 594 0.0243
498 GINGIVITIS 131 0.0243
499 RETINAL HAEMORRHAGE 173 0.0243
500 PERICARDITIS 407 0.0242
501 PATHOGEN RESISTANCE 220 0.0241
502 PANCREATITIS ACUTE 540 0.0240
503 ACUTE KIDNEY INJURY 3674 0.0240
504 GASTROENTERITIS 350 0.0240
505 CARDIAC FAILURE 1923 0.0239
506 LOWER GASTROINTESTINAL HAEMORRHAGE 177 0.0239
507 LYMPHOMA 370 0.0239
508 CLOSTRIDIUM DIFFICILE INFECTION 521 0.0238
509 BLOOD CALCIUM DECREASED 268 0.0238
510 ACUTE MYOCARDIAL INFARCTION 702 0.0238
511 BLOOD URIC ACID INCREASED 137 0.0237
512 MENTAL STATUS CHANGES 658 0.0237
513 LARYNGEAL OEDEMA 146 0.0237
514 VENTRICULAR TACHYCARDIA 391 0.0237
515 APHTHOUS ULCER 183 0.0236
516 HYDROCEPHALUS 128 0.0235
517 DERMATITIS 492 0.0235
518 THERAPY NON-RESPONDER 1054 0.0234
519 ECCHYMOSIS 160 0.0233
520 PNEUMONIA 7514 0.0232
521 BRAIN NEOPLASM 213 0.0232
522 SKIN DISCOLOURATION 1063 0.0231
523 DEATH 19709 0.0229
524 ARTERIOSCLEROSIS CORONARY ARTERY 151 0.0228
525 ANGIOPATHY 127 0.0226
526 OSTEONECROSIS 743 0.0226
527 TACHYCARDIA 2005 0.0225
528 IMMUNODEFICIENCY 335 0.0225
529 ABSCESS 357 0.0224
530 HYPERCALCAEMIA 276 0.0223
531 MELAENA 491 0.0223
532 NAUSEA 17607 0.0222
533 RENAL TUBULAR NECROSIS 218 0.0222
534 SKIN INFECTION 248 0.0221
535 GASTROINTESTINAL INFECTION 198 0.0221
536 MITRAL VALVE INCOMPETENCE 250 0.0221
537 PULMONARY FIBROSIS 422 0.0220
538 RENAL IMPAIRMENT 1847 0.0220
539 ISCHAEMIC STROKE 392 0.0219
540 SKIN LESION 599 0.0218
541 ADRENAL INSUFFICIENCY 263 0.0217
542 COVID-19 PNEUMONIA 255 0.0216
543 HYPERTENSIVE CRISIS 240 0.0216
544 TRICUSPID VALVE INCOMPETENCE 171 0.0215
545 HAEMATURIA 734 0.0214
546 DYSARTHRIA 802 0.0213
547 ASTHENIA 7997 0.0212
548 BLOOD SODIUM DECREASED 400 0.0212
549 ATRIAL FLUTTER 168 0.0210
550 HYPOTENSION 4195 0.0209
551 NEUTROPHIL COUNT INCREASED 214 0.0209
552 SENSORY LOSS 168 0.0208
553 TOXIC EPIDERMAL NECROLYSIS 314 0.0207
554 RESPIRATORY SYNCYTIAL VIRUS INFECTION 180 0.0207
555 RENAL FAILURE 2744 0.0206
556 DYSPHAGIA 1950 0.0205
557 MENINGITIS 137 0.0205
558 CHILLS 2394 0.0204
559 PNEUMONIA ASPIRATION 510 0.0204
560 UPPER GASTROINTESTINAL HAEMORRHAGE 343 0.0204
561 ANGINA PECTORIS 581 0.0203
562 CONJUNCTIVITIS 376 0.0202
563 URINE OUTPUT DECREASED 177 0.0202
564 LIVER DISORDER 895 0.0202
565 UROSEPSIS 186 0.0201
566 CARDIAC ARREST 1662 0.0201
567 WHITE BLOOD CELL COUNT INCREASED 771 0.0201
568 ELECTROCARDIOGRAM ABNORMAL 157 0.0200
569 ALTERED STATE OF CONSCIOUSNESS 433 0.0200
570 SKIN EXFOLIATION 1684 0.0199
571 TENDERNESS 208 0.0199
572 ERYTHEMA MULTIFORME 186 0.0199
573 RECTAL HAEMORRHAGE 855 0.0199
574 FACIAL PARALYSIS 169 0.0198
575 METABOLIC ACIDOSIS 627 0.0196
576 SKIN DISORDER 651 0.0195
577 CONSTIPATION 4242 0.0194
578 GASTROINTESTINAL HAEMORRHAGE 1623 0.0194
579 GASTRITIS 506 0.0192
580 GINGIVAL PAIN 152 0.0191
581 ATRIAL FIBRILLATION 1855 0.0190
582 OSTEOMYELITIS 343 0.0189
583 CENTRAL NERVOUS SYSTEM LESION 259 0.0188
584 BRONCHOSPASM 268 0.0188
585 THERAPY CHANGE 184 0.0187
586 HAEMORRHOIDS 365 0.0187
587 ORAL HERPES 365 0.0187
588 CARDIO-RESPIRATORY ARREST 780 0.0186
589 BONE DISORDER 335 0.0184
590 WOUND INFECTION 201 0.0183
591 STATUS EPILEPTICUS 207 0.0183
592 NERVOUS SYSTEM DISORDER 572 0.0183
593 OEDEMA 990 0.0182
594 HEMIPLEGIA 151 0.0181
595 PLATELET COUNT INCREASED 236 0.0181
596 HEPATITIS 463 0.0181
597 DRUG ERUPTION 320 0.0180
598 TORSADE DE POINTES 141 0.0180
599 TOXICITY TO VARIOUS AGENTS 3003 0.0178
600 RESPIRATORY RATE INCREASED 158 0.0178
601 ACUTE HEPATIC FAILURE 242 0.0177
602 PARAESTHESIA 2785 0.0177
603 OFF LABEL USE 15496 0.0177
604 TOOTH EXTRACTION 220 0.0177
605 PYELONEPHRITIS 153 0.0176
606 BODY TEMPERATURE DECREASED 172 0.0175
607 MASS 244 0.0174
608 SKIN ULCER 451 0.0174
609 ASPIRATION 191 0.0174
610 APHASIA 525 0.0174
611 FOLLICULITIS 182 0.0173
612 FLANK PAIN 162 0.0173
613 BLOOD TEST ABNORMAL 242 0.0172
614 ULCER 274 0.0172
615 SQUAMOUS CELL CARCINOMA 162 0.0172
616 DYSURIA 632 0.0172
617 HAEMOPTYSIS 477 0.0171
618 TOOTH ABSCESS 174 0.0171
619 ANAL INCONTINENCE 152 0.0169
620 INTENTIONAL PRODUCT USE ISSUE 1473 0.0168
621 DECUBITUS ULCER 137 0.0168
622 SCAB 191 0.0167
623 FEEDING DISORDER 338 0.0166
624 INFUSION RELATED REACTION 1104 0.0166
625 FULL BLOOD COUNT ABNORMAL 176 0.0166
626 FATIGUE 12881 0.0165
627 PERIPHERAL COLDNESS 226 0.0164
628 CARDIOMEGALY 202 0.0164
629 TASTE DISORDER 333 0.0164
630 THROMBOSIS 1316 0.0163
631 BLOOD COUNT ABNORMAL 248 0.0163
632 MUSCULOSKELETAL CHEST PAIN 251 0.0162
633 ELECTROCARDIOGRAM QT PROLONGED 582 0.0162
634 LUNG DISORDER 789 0.0161
635 BLISTER 903 0.0161
636 URINARY RETENTION 536 0.0160
637 PRODUCT USE IN UNAPPROVED INDICATION 3979 0.0160
638 GRAND MAL CONVULSION 148 0.0160
639 FLUID OVERLOAD 233 0.0160
640 UNRESPONSIVE TO STIMULI 413 0.0160
641 VENTRICULAR EXTRASYSTOLES 166 0.0160
642 GASTROINTESTINAL DISORDER 1429 0.0159
643 HYPERKALAEMIA 559 0.0159
644 DRUG INTOLERANCE 1530 0.0158
645 INCONTINENCE 167 0.0158
646 RESPIRATORY TRACT INFECTION 411 0.0158
647 VIRAL INFECTION 525 0.0158
648 OEDEMA PERIPHERAL 1908 0.0156
649 GASTRIC HAEMORRHAGE 180 0.0156
650 HAEMORRHAGE 1630 0.0156
651 SPINAL OSTEOARTHRITIS 136 0.0155
652 BONE PAIN 905 0.0154
653 LIVER FUNCTION TEST ABNORMAL 449 0.0154
654 DYSPNOEA EXERTIONAL 576 0.0153
655 ORTHOSTATIC HYPOTENSION 266 0.0153
656 SINUS BRADYCARDIA 147 0.0152
657 IMPAIRED HEALING 498 0.0152
658 THERAPY INTERRUPTED 1080 0.0151
659 VASCULITIS 176 0.0151
660 EPILEPSY 461 0.0151
661 PHARYNGITIS 187 0.0151
662 HYPERLIPIDAEMIA 180 0.0150
663 PANCREATITIS 795 0.0150
664 PAIN IN JAW 426 0.0150
665 PALLOR 407 0.0149
666 PULMONARY THROMBOSIS 163 0.0149
667 DEPRESSED LEVEL OF CONSCIOUSNESS 591 0.0149
668 DIALYSIS 210 0.0148
669 GASTRIC ULCER 280 0.0147
670 HEPATIC CIRRHOSIS 275 0.0146
671 LACRIMATION INCREASED 441 0.0146
672 FACE OEDEMA 244 0.0145
673 ERYTHEMA 2973 0.0144
674 RESPIRATORY DISORDER 431 0.0144
675 EATING DISORDER 306 0.0144
676 HYPERTENSION 3029 0.0143
677 EYELID PTOSIS 145 0.0143
678 SENSORY DISTURBANCE 229 0.0143
679 IMMUNE SYSTEM DISORDER 186 0.0141
680 THERAPY CESSATION 723 0.0141
681 WEIGHT DECREASED 3930 0.0141
682 DELIRIUM 485 0.0140
683 ARRHYTHMIA 661 0.0139
684 NEURALGIA 339 0.0139
685 LETHARGY 801 0.0139
686 HYPOAESTHESIA 2070 0.0138
687 LIVER FUNCTION TEST INCREASED 294 0.0137
688 CHEST PAIN 2533 0.0137
689 SPINAL PAIN 160 0.0136
690 IRON DEFICIENCY ANAEMIA 126 0.0136
691 TOOTHACHE 247 0.0136
692 MOTOR DYSFUNCTION 139 0.0136
693 ABDOMINAL DISTENSION 1407 0.0135
694 SYNCOPE 1346 0.0134
695 ARTERIOSCLEROSIS 125 0.0133
696 GENERALISED TONIC-CLONIC SEIZURE 219 0.0132
697 OXYGEN SATURATION DECREASED 740 0.0132
698 HYPOTHERMIA 133 0.0131
699 HEPATIC ENZYME INCREASED 894 0.0131
700 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 929 0.0130
701 DYSGEUSIA 967 0.0130
702 DIVERTICULITIS 357 0.0129
703 DRY SKIN 1719 0.0129
704 STEVENS-JOHNSON SYNDROME 286 0.0129
705 INFLAMMATION 663 0.0128
706 HAEMATOCHEZIA 702 0.0127
707 EMPHYSEMA 128 0.0127
708 POST PROCEDURAL COMPLICATION 243 0.0126
709 HYPOTHYROIDISM 404 0.0126
710 DIPLOPIA 327 0.0126
711 BASAL CELL CARCINOMA 196 0.0126
712 PULMONARY HYPERTENSION 261 0.0125
713 TREATMENT FAILURE 1036 0.0125
714 BLOOD PRESSURE DECREASED 829 0.0125
715 CYANOSIS 196 0.0125
716 DISORIENTATION 491 0.0124
717 URINARY TRACT INFECTION 2110 0.0124
718 NEOPLASM MALIGNANT 825 0.0123
719 INTERNATIONAL NORMALISED RATIO INCREASED 351 0.0123
720 ABDOMINAL PAIN LOWER 311 0.0123
721 BREAST CANCER 1143 0.0123
722 DERMATITIS ALLERGIC 154 0.0122
723 COMA 576 0.0121
724 CYSTITIS 385 0.0121
725 HYPOAESTHESIA ORAL 181 0.0120
726 RETCHING 256 0.0120
727 RASH ERYTHEMATOUS 574 0.0120
728 PARAESTHESIA ORAL 173 0.0120
729 ILL-DEFINED DISORDER 726 0.0119
730 RASH 5201 0.0119
731 URINARY INCONTINENCE 353 0.0119
732 CHOLELITHIASIS 390 0.0119
733 BREAST PAIN 126 0.0118
734 FAECES DISCOLOURED 256 0.0118
735 TRANSIENT ISCHAEMIC ATTACK 398 0.0118
736 HERPES ZOSTER 676 0.0118
737 TUBULOINTERSTITIAL NEPHRITIS 218 0.0116
738 DYSPNOEA 6558 0.0116
739 DENTAL CARIES 128 0.0116
740 PARALYSIS 165 0.0115
741 ALOPECIA 2261 0.0115
742 DRUG INTERACTION 1823 0.0115
743 CONVULSION 657 0.0115
744 ANAPHYLACTIC SHOCK 296 0.0115
745 ANAPHYLACTIC REACTION 634 0.0115
746 BLOOD POTASSIUM INCREASED 186 0.0114
747 DYSPHONIA 668 0.0114
748 NODULE 149 0.0114
749 HAIR COLOUR CHANGES 142 0.0114
750 MADAROSIS 132 0.0114
751 CONFUSIONAL STATE 1793 0.0111
752 ABDOMINAL PAIN UPPER 2265 0.0110
753 MUSCULAR WEAKNESS 1238 0.0109
754 PHOTOSENSITIVITY REACTION 179 0.0108
755 UPPER RESPIRATORY TRACT INFECTION 500 0.0108
756 DEAFNESS 282 0.0108
757 FEELING COLD 296 0.0106
758 HAEMATOMA 271 0.0104
759 BRADYCARDIA 552 0.0104
760 DEVICE OCCLUSION 146 0.0104
761 SEIZURE 1198 0.0104
762 BACK PAIN 2392 0.0103
763 PRESYNCOPE 243 0.0100
764 IMPAIRED QUALITY OF LIFE 143 0.0099
765 TOOTH INFECTION 130 0.0099
766 SARS-COV-2 TEST POSITIVE 130 0.0098
767 SPEECH DISORDER 515 0.0098
768 PULMONARY CONGESTION 129 0.0098
769 DYSPEPSIA 959 0.0097
770 HAIR TEXTURE ABNORMAL 130 0.0097
771 LACTIC ACIDOSIS 314 0.0097
772 LABORATORY TEST ABNORMAL 285 0.0096
773 COUGH 2695 0.0096
774 LOCALISED INFECTION 232 0.0096
775 RENAL DISORDER 445 0.0095
776 COVID-19 1662 0.0095
777 THROAT TIGHTNESS 256 0.0095
778 CHROMATURIA 213 0.0094
779 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 515 0.0094
780 BLOOD URINE PRESENT 178 0.0094
781 PAIN IN EXTREMITY 2758 0.0094
782 ORAL DISCOMFORT 130 0.0093
783 DIABETIC KETOACIDOSIS 223 0.0093
784 BURNING SENSATION 647 0.0092
785 EAR PAIN 179 0.0092
786 BLINDNESS 372 0.0091
787 DRUG LEVEL INCREASED 151 0.0091
788 FLATULENCE 514 0.0091
789 MUSCULOSKELETAL PAIN 474 0.0090
790 HYPERSENSITIVITY 1677 0.0090
791 HYPOGLYCAEMIA 433 0.0089
792 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 153 0.0089
793 PULMONARY ARTERIAL HYPERTENSION 129 0.0089
794 PRODUCTIVE COUGH 423 0.0089
795 COGNITIVE DISORDER 413 0.0088
796 SKIN HAEMORRHAGE 131 0.0088
797 GASTRIC CANCER 221 0.0087
798 MALAISE 3821 0.0087
799 NIGHT SWEATS 280 0.0087
800 POLLAKIURIA 362 0.0087
801 CHEST DISCOMFORT 885 0.0086
802 TOOTH DISORDER 192 0.0086
803 PHOTOPHOBIA 161 0.0086
804 COLD SWEAT 150 0.0085
805 OSTEOPENIA 129 0.0085
806 LOSS OF CONSCIOUSNESS 1084 0.0085
807 THERAPEUTIC RESPONSE DECREASED 512 0.0084
808 OROPHARYNGEAL PAIN 781 0.0084
809 FREQUENT BOWEL MOVEMENTS 227 0.0084
810 PRODUCT PRESCRIBING ISSUE 181 0.0083
811 PREMATURE DELIVERY 132 0.0083
812 CARDIAC FAILURE CONGESTIVE 655 0.0081
813 DRY MOUTH 653 0.0080
814 RHINORRHOEA 517 0.0080
815 RASH PRURITIC 433 0.0080
816 PERIPHERAL SWELLING 1209 0.0078
817 GASTROOESOPHAGEAL REFLUX DISEASE 631 0.0078
818 HOSPITALISATION 1204 0.0078
819 PRODUCT USE ISSUE 1466 0.0078
820 RASH MACULAR 272 0.0078
821 GAIT INABILITY 260 0.0078
822 PANCREATIC CARCINOMA 224 0.0077
823 BLOOD CREATINE PHOSPHOKINASE INCREASED 223 0.0077
824 LOCAL SWELLING 135 0.0077
825 LIP SWELLING 257 0.0077
826 PELVIC PAIN 140 0.0077
827 FRACTURE 145 0.0077
828 WOUND 214 0.0076
829 DRUG EXPOSURE DURING PREGNANCY 257 0.0075
830 PREMATURE BABY 226 0.0075
831 RASH PAPULAR 168 0.0075
832 HEART RATE INCREASED 742 0.0075
833 CONDITION AGGRAVATED 2243 0.0074
834 AGEUSIA 184 0.0074
835 CARDIOVASCULAR DISORDER 186 0.0073
836 CARDIAC DISORDER 685 0.0073
837 VISUAL ACUITY REDUCED 243 0.0073
838 CEREBROVASCULAR ACCIDENT 1238 0.0073
839 LOWER RESPIRATORY TRACT INFECTION 331 0.0073
840 GAIT DISTURBANCE 1387 0.0072
841 GOUT 130 0.0072
842 BLOOD TRIGLYCERIDES INCREASED 128 0.0072
843 DRUG INEFFECTIVE 9506 0.0072
844 PAIN OF SKIN 194 0.0072
845 PRODUCT DOSE OMISSION IN ERROR 204 0.0072
846 RIB FRACTURE 148 0.0072
847 PAIN 4412 0.0072
848 SWOLLEN TONGUE 224 0.0072
849 RESPIRATORY ARREST 196 0.0071
850 MUSCULOSKELETAL DISORDER 135 0.0071
851 BALANCE DISORDER 611 0.0071
852 MUSCLE TWITCHING 162 0.0070
853 PRODUCT ADMINISTRATION ERROR 142 0.0070
854 DIZZINESS 3472 0.0070
855 BLOOD PRESSURE SYSTOLIC INCREASED 135 0.0069
856 HEART RATE DECREASED 243 0.0069
857 FLUSHING 701 0.0069
858 NECK PAIN 385 0.0069
859 FEELING HOT 422 0.0069
860 HYPERHIDROSIS 884 0.0069
861 ABASIA 169 0.0068
862 MYOCARDIAL INFARCTION 1189 0.0068
863 CORONARY ARTERY DISEASE 205 0.0068
864 FALL 2247 0.0067
865 UNEVALUABLE EVENT 503 0.0066
866 DRY EYE 331 0.0066
867 SKIN CANCER 142 0.0066
868 MUSCLE SPASMS 1201 0.0065
869 SWELLING FACE 424 0.0065
870 ERUCTATION 125 0.0065
871 INTERVERTEBRAL DISC PROTRUSION 141 0.0064
872 BLOOD PRESSURE INCREASED 986 0.0064
873 CONTUSION 612 0.0064
874 APPLICATION SITE PAIN 140 0.0063
875 DYSSTASIA 185 0.0063
876 VERTIGO 386 0.0063
877 ABDOMINAL DISCOMFORT 1061 0.0063
878 HYPERSOMNIA 180 0.0063
879 SWELLING 586 0.0063
880 MYALGIA 1058 0.0062
881 RASH GENERALISED 160 0.0062
882 FLUID RETENTION 314 0.0062
883 PRURITUS 2358 0.0061
884 HEADACHE 3825 0.0061
885 HIP FRACTURE 196 0.0061
886 RHABDOMYOLYSIS 252 0.0060
887 FEMUR FRACTURE 187 0.0060
888 HEAD INJURY 191 0.0060
889 DIABETES MELLITUS 457 0.0060
890 APPLICATION SITE ERYTHEMA 157 0.0060
891 DISCOMFORT 364 0.0060
892 NEPHROLITHIASIS 268 0.0058
893 PALPITATIONS 683 0.0058
894 RESTLESSNESS 212 0.0058
895 TREMOR 958 0.0058
896 ANGIOEDEMA 255 0.0058
897 ADVERSE DRUG REACTION 517 0.0058
898 LIMB DISCOMFORT 178 0.0057
899 SOMNOLENCE 1152 0.0057
900 GLOSSODYNIA 128 0.0057
901 HEART RATE IRREGULAR 128 0.0057
902 BRONCHITIS 419 0.0057
903 RENAL INJURY 167 0.0056
904 COLORECTAL CANCER 268 0.0056
905 ADVERSE EVENT 512 0.0056
906 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 993 0.0055
907 SINUSITIS 564 0.0055
908 ECZEMA 283 0.0054
909 NO ADVERSE EVENT 975 0.0054
910 SURGERY 315 0.0054
911 AGITATION 391 0.0053
912 HOT FLUSH 390 0.0052
913 GASTRIC DISORDER 177 0.0052
914 TINNITUS 235 0.0051
915 MOVEMENT DISORDER 164 0.0051
916 DEPRESSED MOOD 266 0.0050
917 VISION BLURRED 685 0.0050
918 EYE DISORDER 162 0.0049
919 THROAT IRRITATION 217 0.0048
920 VISUAL IMPAIRMENT 599 0.0048
921 DRUG EFFECT INCOMPLETE 174 0.0048
922 HALLUCINATION 358 0.0047
923 VAGINAL HAEMORRHAGE 206 0.0047
924 MEDICATION ERROR 260 0.0047
925 ILLNESS 478 0.0046
926 AMNESIA 300 0.0046
927 ARTHRALGIA 1909 0.0046
928 CATARACT 273 0.0046
929 OSTEOARTHRITIS 194 0.0046
930 EYE SWELLING 170 0.0046
931 INSOMNIA 1215 0.0046
932 DEMENTIA 127 0.0045
933 OSTEOPOROSIS 186 0.0045
934 OESOPHAGEAL CARCINOMA 134 0.0045
935 INFLUENZA 495 0.0044
936 SLEEP DISORDER 312 0.0044
937 EMOTIONAL DISORDER 135 0.0044
938 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 209 0.0043
939 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 227 0.0043
940 MOBILITY DECREASED 309 0.0043
941 EYE PAIN 242 0.0043
942 TYPE 2 DIABETES MELLITUS 144 0.0043
943 NASOPHARYNGITIS 771 0.0042
944 MEMORY IMPAIRMENT 572 0.0042
945 LUNG NEOPLASM MALIGNANT 169 0.0041
946 EYE IRRITATION 233 0.0040
947 WHEEZING 237 0.0040
948 ANXIETY 1133 0.0040
949 TREATMENT NONCOMPLIANCE 217 0.0040
950 WEIGHT INCREASED 887 0.0040
951 ACNE 298 0.0039
952 HYPOACUSIS 169 0.0039
953 DYSKINESIA 157 0.0039
954 UNDERDOSE 274 0.0037
955 OCULAR HYPERAEMIA 177 0.0037
956 CHRONIC KIDNEY DISEASE 281 0.0037
957 DEPRESSION 840 0.0037
958 URTICARIA 618 0.0037
959 MATERNAL EXPOSURE DURING PREGNANCY 327 0.0037
960 MUSCULOSKELETAL STIFFNESS 314 0.0036
961 DISTURBANCE IN ATTENTION 191 0.0035
962 INFLUENZA LIKE ILLNESS 289 0.0035
963 ACCIDENTAL OVERDOSE 128 0.0035
964 MENTAL DISORDER 152 0.0035
965 PLASMA CELL MYELOMA 136 0.0035
966 SKIN IRRITATION 159 0.0035
967 FOETAL EXPOSURE DURING PREGNANCY 271 0.0033
968 ARTHRITIS 259 0.0033
969 BLOOD GLUCOSE INCREASED 618 0.0033
970 FEELING ABNORMAL 767 0.0032
971 ROAD TRAFFIC ACCIDENT 132 0.0032
972 ARTHROPATHY 172 0.0031
973 BLOOD CHOLESTEROL INCREASED 142 0.0030
974 EXPOSURE DURING PREGNANCY 189 0.0030
975 SKIN BURNING SENSATION 217 0.0030
976 NASAL CONGESTION 172 0.0029
977 INJECTION SITE REACTION 197 0.0029
978 INJURY 201 0.0029
979 IRRITABILITY 171 0.0028
980 JOINT SWELLING 342 0.0028
981 BLOOD GLUCOSE DECREASED 126 0.0026
982 DRUG EFFECT DECREASED 141 0.0026
983 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 158 0.0022
984 MIGRAINE 193 0.0020
985 OVERDOSE 426 0.0020
986 PRODUCT DOSE OMISSION ISSUE 567 0.0019
987 ASTHMA 205 0.0018
988 EMOTIONAL DISTRESS 219 0.0018
989 INJECTION SITE ERYTHEMA 190 0.0015
990 DRUG DOSE OMISSION 246 0.0015
991 INTENTIONAL PRODUCT MISUSE 128 0.0015
992 INCORRECT DOSE ADMINISTERED 328 0.0014
993 PRODUCT QUALITY ISSUE 129 0.0009
994 INJECTION SITE PAIN 278 0.0009
995 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 177 0.0009